RETRACTION: Apelin‐13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI‐3K/Akt and MAPK/Erk Signaling Pathways
BioMed Research International · 2026-01 · 2026 (1)
DOI: 10.1155/bmri/9757309 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 31.03.2026. Verfasst von BioMed Research International. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Research International, B. (2026). RETRACTION: Apelin‐13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI‐3K/Akt and MAPK/Erk Signaling Pathways. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/9757309
Vancouver
Research International B. RETRACTION: Apelin‐13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI‐3K/Akt and MAPK/Erk Signaling Pathways. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/9757309
BibTeX
@article{ResearchInternational2026,
author = {Research International, BioMed},
title = {RETRACTION: Apelin‐13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI‐3K/Akt and MAPK/Erk Signaling Pathways},
journal = {BioMed Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bmri/9757309}
}
EUVIMED